NeuroVigil, Inc.
PrivateLast Round
Series B
Apr 5, 2024
Est. Valuation
$6B
Total Funding Raised
$85.28M
Company Overview
NeuroVigil, Inc. is a neurotechnology company that develops proprietary non-invasive brain monitors and advanced machine learning algorithms to detect a constellation of biomarkers of pathologies in asymptomatic individuals.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NeuroVigil, Inc. Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
NeuroVigil, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 5, 2024 | ||||
| Series A | May 4, 2015 | ||||
| Series A | Apr 1, 2015 | ||||
| Seed | May 1, 2011 | ||||
| Grant | Jul 2, 2008 | ||||
Seed | May 30, 2008 |
NeuroVigil, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DFJ Frontier | Seed |
| Zone Ventures | Series A, Seed |
| University of Waterloo | Series B |
| Draper Fisher Jurvetson Management | Series A, Seed |
| DFJ Growth | Series A |
| Draper Associates | Series A, Seed |
| Wilson Sonsini Goodrich & Rosati | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 10, 2025
Named a Top 10 Most Innovative Company in Health Care by Fast Company.
- Apr 5, 2024
$85M round with participation from 2b AHEAD Ventures.
NeuroVigil, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Appears On
Curated lists and screens where this company is featured.
Frequently Asked Questions
Common questions about NeuroVigil, Inc.'s valuation, stock price, and market status.